Email Us

Excellent List丨Hygea Medical was Awarded '2021 Best Enterprise of Innovative Medical Devices Award'

On April 3nd, 2022, Haoyue Capital, an industrial investment bank focusing on Chinese medical and health care, officially released the "2022 6th Medical and Health Investment Excellent List". Hygea Medical was awarded the "2021 Best Enterprise of Innovative Medical Devices Award".


2022 6th Medical and Health Investment Excellent List


As an annual authoritative list highly recognized by the industry, since its first release in 2017, the Medical and Health Investment Excellent List has always adhered to the principles of fairness, impartiality, objectivity and neutrality. Data and information was filled in by various institutions. Through the form of "authoritative judges, one vote per organization" real-name voting, comprehensively sort out the investment activity, transaction volume, transaction amount and investment return of each medical and health investment fund, and select the annual excellent investment institutions. At the same time, the Excellent List also awards to outstanding medical and health companies in different fields such as biopharmaceuticals, innovative medical devices, in vitro diagnostics, medical services, and WITMED, etc. It can set a new benchmark for industry development and create new opportunities for investment cooperation.In recent years, based on innovation leadership, technological breakthroughs and platform construction, Hygea Medical has created a series of domestic leading solutions for minimally invasive tumor intervention.


In 2021, Hygea Medical successfully completed the financing of round C and round C+ , and started the whole platform layout in the field of tumor ablation therapy. The core product Cryosurgical System was approved to be included in the medical insurance catalogue, marking the company's successful completion of the entire process of industrialization of innovative devices. At the same time, new products such as other tumor ablation devices and artificial intelligence-based surgical planning systems were developed and finalized, and started the research and development of vascular intervention solution simultaneously. Layout in the field of vascular intervention, a series of vascular intervention products have entered the research and development. The company is building an aircraft carrier of minimally invasive tumor interventional therapy technology with a rich product pipeline and a full-field layout.As an advanced medical technology company in the field of minimally invasive tumor intervention, Hygea Medical has always adhered to the values and development philosophy of "YOUR HEALTH OUR CONCERN". 


In the future, Hygea Medical will further expand its product pipeline, accelerate technological innovation, promote business growth, and launch more advanced products for more doctors and patients. Hygea Medical looks forward to work hand in hand with Haoyue Capital and other industry colleagues, gathering momentum and planning for the future, and jointly contributing wisdom and strength to the steady development of Chinese medical and health cause.


Clinical Applications of our Co-Ablation System

 

Hygea Medical Technology Co., Ltd.
We are committed to building a platform-type innovative medical device enterprise for minimally invasive treatment, and helping China's medical devices and China's minimally invasive to realize the curved road to overtake.